| FMDCX | VIEIX | FMDCX / VIEIX | |
| Total Expense Ratio | 0.57 | 0.04 | 1,425% |
| Annual Report Gross Expense Ratio | 0.76 | 0.04 | 1,900% |
| Fund Existence | 34 years | 29 years | - |
| Gain YTD | 12.318 | 13.069 | 94% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 5000000 | 20% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 275M | 95.3B | 0% |
| Annual Yield % from dividends | 0.75 | 1.01 | 74% |
| Returns for 1 year | 2.39 | 12.28 | 19% |
| Returns for 3 years | 7.23 | 59.79 | 12% |
| Returns for 5 years | -22.32 | 27.90 | -80% |
| Returns for 10 years | -27.21 | 175.87 | -15% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FESM | 46.36 | 0.36 | +0.78% |
| Fidelity Enhanced Small Cap Core ETF | |||
| YDEC | 28.18 | 0.06 | +0.21% |
| FT Vest Intl Eq Mod Bffr ETF Dec | |||
| RCLO | 25.11 | 0.03 | +0.12% |
| Reckoner BBB-B CLO ETF | |||
| BSCY | 19.97 | -0.02 | -0.08% |
| Invesco BulletShares 2034 Corp Bd ETF | |||
| THNR | 25.59 | -0.41 | -1.59% |
| Amplify Weight Loss Drug & Treatment ETF | |||